Abuse Potential of Pregabalin

doi:10.1007/s40263-015-0303-6

Paper

Abuse Potential of Pregabalin

Published Jan 14, 2016 · O. Schjerning, M. Rosenzweig, A. Pottegård

CNS Drugs

Q1 SJR score

95

Citations

1

Influential Citations

Full textSemantic Scholar

Abstract

BackgroundSeveral case reports and epidemiological studies have raised concern about the abuse potential of pregabalin, the use of which has increased substantially over the last decade. Pregabalin is, in some cases, used for recreational purposes and it has incurred attention among drug abusers for causing euphoric and dissociative effects when taken in doses exceeding normal therapeutic dosages or used by alternative routes of administration, such as nasal insufflation or venous injection. The magnitude of the abuse potential and the mechanism behind it are not fully known.ObjectiveThe aim of this study was to present a systematic review of the data concerning the abuse potential of pregabalin.MethodsWe performed a systematic literature search and reviewed the preclinical, clinical and epidemiological data on the abuse potential of pregabalin.ResultsWe included preclinical (n = 17), clinical (n = 19) and epidemiological (n = 13) studies addressing the abuse potential of pregabalin. We also reviewed case reports (n = 9) concerning abuse of pregabalin. The preclinical studies indicated that pregabalin possesses modulatory effects on the GABA and glutamate systems, leaving room for an abuse potential. Further, clinical studies reported euphoria as a frequent side effect in patients treated with pregabalin. The majority of case reports concerning abuse of pregabalin involved patients with a history of substance abuse and, similarly, epidemiological studies found evidence of abuse, especially among opiate abusers.ConclusionsOverall, the available literature suggests an important clinical abuse potential of pregabalin and prescribers should pay attention to signs of abuse, especially in patients with a history of substance abuse.

Systematic Review

Very Rigorous Journal

Highly Cited

Study Snapshot

Pregabalin has a significant clinical abuse potential, especially among patients with a history of substance abuse.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

Abuse Potential of Pregabalin

Sign up to use Study Snapshot

References

Pregabalin May Cause Dependence Even if It is not Abused

Pregabalin use may lead to drug dependence even if it is not abused, as seen in cases presented in this study.

Pregabalin dependence: a case report.

Pregabalin dependence can occur in patients without a history of substance abuse, highlighting the need for physicians to be aware of its addictive potential.

Prescription medication misuse among opioid dependent patients seeking inpatient detoxification.

High rates of medication misuse were found in opioid dependent patients seeking detoxification, similar to rates found among controlled substances like clonazepam and amphetamine salts.

GABAB receptors as a therapeutic strategy in substance use disorders: Focus on positive allosteric modulators

Positive allosteric modulators (PAMs) of GABA B receptors show potential therapeutic efficacy in drug addiction, with effects similar to those of baclofen and anxiolytic effects.

Pregabalin role in inhibition of morphine analgesic tolerance and physical dependency in rats.

Pregabalin 200 mg/kg completely prevents morphine tolerance and reduces withdrawal signs in rats, making it a promising candidate for treating opioid addiction.

Citations

Perceptions of community pharmacists regarding pregabalin abuse: a survey from Sudan.

Most community pharmacists in Sudan have observed pregabalin abuse and believe it is increasing, primarily managing the issue by reporting the drug unavailable and refusing to dispense it.

National impact of a constraining regulatory framework on pregabalin dispensations in France, 2020-2022.

The constraining regulation adopted in 2021 by French health authorities significantly curtailed total pregabalin dispensing in community pharmacies, highlighting the importance of regulatory measures to limit misuse of prescribed medications.

Experiences of misuse and symptoms of dependence among people who use gabapentinoids: A qualitative systematic review.

Gabapentinoids can be misused for various reasons, leading to rapid tolerance development and severe withdrawal symptoms, which can help develop effective harm reduction strategies.

Characteristics of Non-Therapeutic Pregabalin Users Detected by a Community Pharmacies Network in a Region of Southern Europe

Non-therapeutic use of pregabalin is prevalent among the Catalan population, with potential recreational use in patients aged 25 and 25-35 years, and a need for control measures and education on risks.

Gabapentinoid prescribing patterns and predictors utilizing neural networks: An analysis across emergency departments Nationwide between 2012 and 2021.

Gabapentinoids were increasingly prescribed at ED discharge between 2012 and 2021, potentially offering safer alternatives to opioids, but increased prescribing may lead to increased misuse and overdose.

Understanding pregabalin misuse and dependence: Insights from a North Indian addiction treatment center

Pregabalin dependence is prevalent among individuals seeking substance use disorder treatment in North India, with higher odds among those with opioid dependence.

The Swiss Prison Study (SWIPS): Results from a registry-based study of prisoners in Switzerland from 2015 to 2020.

Inmates in Swiss prisons from 2015 to 2020 experienced a significant increase in antipsychotic and anticonvulsant use, while decreasing analgesic and antianxiety drug use.

Anxiety disorders, post-traumatic stress disorder and obsessive–compulsive disorder

Anxiety disorders, post-traumatic stress disorder, and obsessive-compulsive disorder, are common and can cause significant personal distress and impairment, but accurate diagnosis and treatment depend on the severity and impact of symptoms.